Lymphangiogenesis-related gene signature-based risk model for prognostic assessment of cervical cancer: immune-metabolic characterization and molecular subtype analysis.

Fan X, Chen L, Xu J, Zheng S, Pan Q, Hu Y.

Open source

DOI
10.3389/fgene.2026.1835653
Published
2026-08-31
Container
Front Genet
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fgene.2026.1835653,
  title = {Lymphangiogenesis-related gene signature-based risk model for prognostic assessment of cervical cancer: immune-metabolic characterization and molecular subtype analysis.},
  author = {Fan X and  Chen L and  Xu J and  Zheng S and  Pan Q and  Hu Y.},
  year = {2026},
  journal = {Front Genet},
  doi = {10.3389/fgene.2026.1835653},
  url = {https://doi.org/10.3389/fgene.2026.1835653}
}

RIS

TY  - JOUR
TI  - Lymphangiogenesis-related gene signature-based risk model for prognostic assessment of cervical cancer: immune-metabolic characterization and molecular subtype analysis.
AU  - Fan X
AU  -  Chen L
AU  -  Xu J
AU  -  Zheng S
AU  -  Pan Q
AU  -  Hu Y.
PY  - 2026
JO  - Front Genet
DO  - 10.3389/fgene.2026.1835653
UR  - https://doi.org/10.3389/fgene.2026.1835653
ER  - 

APA

X, F., L, C., J, X., S, Z., Q, P., & Y., H. (2026). Lymphangiogenesis-related gene signature-based risk model for prognostic assessment of cervical cancer: immune-metabolic characterization and molecular subtype analysis.. Front Genet. https://doi.org/10.3389/fgene.2026.1835653

Source records